Showing 2721-2740 of 7110 for: Cochrane Systematic Reviews Back
- House dust mite control measures for asthma
Cochrane Systematic Reviews, 15-Aug-2011
The major allergen in house dust comes from mites. Chemical, physical and combined methods of reducing mite allergen levels are intended to reduce asthma symptoms in people who are sensitive to house dust mites.
- House dust mite reduction and avoidance measures for treating eczema
Cochrane Systematic Reviews, 19-Jan-2015
Eczema is an inflammatory skin disease that tends to involve skin creases, such as the folds of the elbows or knees; it is an intensely itchy skin condition, which can relapse and remit over time. As many as a third of people with eczema who have a positi
- House modifications for preventing malaria
Cochrane Systematic Reviews, 22-Sep-2022
Malaria remains an important public health problem. Research in 1900 suggested house modifications may reduce malaria transmission. A previous version of this review concluded that house screening may be effective in reducing malaria. This update includes
- Household interventions for preventing domestic lead exposure in children
Cochrane Systematic Reviews, 16-Dec-2014
Lead poisoning is associated with physical, cognitive and neurobehavioural impairment in children and trials have tested many household interventions to prevent lead exposure. This is an update of the original review by the same authors first published in
- Housing improvements for health and associated socio-economic outcomes
Cochrane Systematic Reviews, 27-Feb-2013
The well established links between poor housing and poor health indicate that housing improvement may be an important mechanism through which public investment can lead to health improvement. Intervention studies which have assessed the health impacts of
- Human albumin for intradialytic hypotension in haemodialysis patients
Cochrane Systematic Reviews, 4-Oct-2010
Intradialytic hypotension (IDH) occurs in 20% to 55% of haemodialysis sessions and is more frequent among patients on long-term haemodialysis. Symptomatic IDH is generally defined as a decrease in systolic blood pressure (BP) of at least 10 mm Hg or a sys
- Human albumin solution for resuscitation and volume expansion in critically ill patients
Cochrane Systematic Reviews, 3-Oct-2011
Human albumin solutions are used for a range of medical and surgical problems. Licensed indications are the emergency treatment of shock and other conditions where restoration of blood volume is urgent, such as in burns and hypoproteinaemia. Human albumin
- Human chorionic gonadotrophin (hCG) for preventing miscarriage
Cochrane Systematic Reviews, 10-Dec-2012
Recurrent miscarriage (RM) is defined as the loss of three or more consecutive pregnancies. Further research is required to understand the causes of RM, which remain unknown for many couples. Human chorionic gonadotrophin (hCG) is vital for maintaining th
- Human chorionic gonadotrophin for recurrent miscarriage
Cochrane Systematic Reviews, 11-Jun-2008
There may be an association between recurrent miscarriage and abnormal hormone function in the follicular phase. Human chorionic gonadotrophin may play a role in preventing miscarriages.
- Human chorionic gonadotrophin for threatened miscarriage
Cochrane Systematic Reviews, 13-Apr-2010
Miscarriage is a common occurrence in early pregnancy. Human chorionic gonadotrophin (hCG) is secreted by the syncytiotrophoblast. It promotes the corpus luteum to secrete progesterone and helps in maintaining the pregnancy. Hence, there has been much int
- Human growth hormone and glutamine for patients with short bowel syndrome
Cochrane Systematic Reviews, 22-Apr-2010
There has been clinical enthusiasm for treating short bowel patients with human recombinant growth hormone and/or glutamine in hopes of reducing parenteral nutrition dependency. It has been more than a decade since Byrne and colleagues reported enhanced a
- 'Human' insulin versus animal insulin in people with diabetes mellitus
Cochrane Systematic Reviews, 10-Nov-2008
Human insulin was introduced for the routine treatment of diabetes mellitus in the early 1980s without adequate comparison of efficacy to animal insulin preparations. First reports of altered hypoglycaemia awareness after transfer to human insulin made ph
- Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions
Cochrane Systematic Reviews, 1-Apr-2015
Atypical squamous cells of undetermined significance (ASCUS) and low-grade squamous intra-epithelial lesions (LSIL) are minor lesions of the cervical epithelium, detectable by cytological examination of cells collected from the surface of the cervix of a
- Human recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver diseases
Cochrane Systematic Reviews, 14-Feb-2012
Mortality from upper gastrointestinal bleeding in patients with liver disease is high. Recombinant human activated factor VII (rHuFVIIa) has been suggested for patients with liver disease and upper gastrointestinal bleeding.
- Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients
Cochrane Systematic Reviews, 2-Nov-2012
Sepsis is a common and frequently fatal condition. Human recombinant activated protein C (APC) has been introduced to reduce the high risk of death associated with severe sepsis or septic shock. This systematic review is an update of a Cochrane review ori
- Humanized PA14 (a monoclonal CCR5 antibody) for treatment of people with HIV infection
Cochrane Systematic Reviews, 25-Jul-2014
PRO 140 (a humanized form of the PA14 antibody, a monoclonal CCR5 antibody) inhibits CCR5-tropic (R5) type 1 human immunodeficiency virus (HIV). This may be an effective new treatment with the potential to address the limitations of currently available th
- Humidification of indoor air for preventing or reducing dryness symptoms or upper respiratory infections in educational settings and at the workplace
Cochrane Systematic Reviews, 10-Dec-2021
Indoor exposure to dry air during heating periods has been associated with dryness and irritation symptoms of the upper respiratory airways and the skin. The irritated or damaged mucous membrane poses an important entry port for pathogens causing respirat
- Huperzine A for Alzheimer's disease
Cochrane Systematic Reviews, 3-Nov-2008
Alzheimer's disease (AD) has become a major public health problem around the world due to its increasing prevalence, long duration, caregiver burden, and high financial cost of care. The degeneration of acetylcholine-containing neurons in the basal forebr
- Huperzine A for mild cognitive impairment
Cochrane Systematic Reviews, 9-Nov-2012
Mild cognitive impairment (MCI) has been proposed as a condition of intermediate symptomatology between the cognitive changes of ageing and fully developed symptoms of dementia. Treatment in the stages of MCI may delay the deterioration of cognitive impai
- Huperzine A for vascular dementia
Cochrane Systematic Reviews, 30-Jun-2011
Huperzine A, a form of herbal medicine, has been considered as an alternative treatment for vascular dementia (VaD) in China.
